Dr. Silverstein answers: 'What If More Cancer is Found During Lumpectomy?' — -- Question: What will the surgeon do if more cancer is evident during lumpectomy surgery? Answer: If more cancer is ...

Lumpectomy is the gold standard for breast cancer surgery, says Kirstyn E. Brownson, MD, a surgical breast oncologist at Huntsman Cancer Institute. We asked Dr. Brownson to explain what a lumpectomy ...

DOCTOR, MOST PEOPLE ASSOCIATE BREAST RECONSTRUCTION WITH THE SINGLE OR DOUBLE MASTECTOMY. BUT WHAT ABOUT A LUMPECTOMY, WHEN ONLY PART OF THE BREAST IS REMOVED? JOINING US LIVE THIS MORNING IS MERCY ...

For many years, lumpectomy has been the most common surgical procedure to treat breast cancer. In a 2014 study in the Journal of the American Medical Association, researchers examined medical records ...

Breast cancer death rates have been declining since 1989, but the disease remains the second leading cause of cancer death in women. And incidence rates have increased slightly in recent years. For ...

Many patients undergoing lumpectomy surgery at NYU Langone Medical Center for the removal of an early detected breast tumor - the surgical option of choice for this diagnosis -- are benefitting from ...

As many as 40% of lumpectomies leave positive margins that necessitate a second surgery, but a novel fluorescent imaging agent used along with a direct visualization system may improve complete ...

DEAR MAYO CLINIC: I understand surgery is often included as part of the treatment plan for breast cancer. If I'm a candidate for lumpectomy but am also considering a mastectomy, what are some things I ...

Lumpectomy procedures have become more refined in combination with chemotherapy and radiation, allowing women with breast cancer to conserve more of their breasts when undergoing treatment, according ...

The MarketWatch News Department was not involved in the creation of this content. NEWTON, Mass., Dec. 18, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided ...

Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and Drug ...

NEWTON, Mass., Dec. 18, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with ...